Close Menu

NEW YORK (GenomeWeb) – RNA products developer Cofactor Genomics announced today that it has acquired San Francisco-based biomarker development company Narus Biotechnologies.

The acquisition of Narus — which has been focused on creating RNA-based diagnostics for neurological diseases such as Alzheimer's and Parkinson's — will help Cofactor to further expand into the realm of RNA diagnostics, and to develop its plans to create RNA-based tests for cancer and neurodegenerative diseases, the company said.

Terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A letter criticizing actions by the US government and research institutions toward Chinese and Chinese-American scientists has garnered more than a hundred signatories.

NPR reports that researchers in New York are investigating whether it is possible to edit the genomes of human sperm.

In an opinion piece at the Nation, Sarah Lawrence College's Laura Hercher argues that everyone should be able to access prenatal genetic testing.

In Nature this week: ancient DNA uncovers presence of Mediterranean migrants at a Himalayan lake, and more.